Ovid Therapeutics Inc (OVID)
3.005
-0.04
(-1.48%)
USD |
NASDAQ |
May 10, 16:00
3.005
0.00 (0.00%)
After-Hours: 18:17
Ovid Therapeutics Total Liabilities (Quarterly): 56.23M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 56.23M |
September 30, 2023 | 23.74M |
June 30, 2023 | 25.53M |
March 31, 2023 | 22.42M |
December 31, 2022 | 22.99M |
September 30, 2022 | 22.98M |
June 30, 2022 | 25.18M |
March 31, 2022 | 26.10M |
December 31, 2021 | 14.80M |
September 30, 2021 | 10.06M |
June 30, 2021 | 11.29M |
March 31, 2021 | 16.35M |
December 31, 2020 | 32.29M |
September 30, 2020 | 27.96M |
June 30, 2020 | 14.87M |
Date | Value |
---|---|
March 31, 2020 | 10.28M |
December 31, 2019 | 10.82M |
September 30, 2019 | 10.65M |
June 30, 2019 | 9.470M |
March 31, 2019 | 9.410M |
December 31, 2018 | 8.844M |
September 30, 2018 | 10.42M |
June 30, 2018 | 7.496M |
March 31, 2018 | 6.579M |
December 31, 2017 | 6.021M |
September 30, 2017 | 4.608M |
June 30, 2017 | 7.065M |
March 31, 2017 | 4.868M |
December 31, 2016 | 3.733M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.470M
Minimum
Jun 2019
56.23M
Maximum
Dec 2023
20.74M
Average
22.42M
Median
Mar 2023
Total Liabilities (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 107.35M |
NovaBay Pharmaceuticals Inc | 5.72M |
Palatin Technologies Inc | 24.94M |
iBio Inc | 24.82M |
Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 144.03M |
Shareholders Equity (Quarterly) | 87.80M |
Current Ratio | 9.552 |